AmerisourceBergen Corp. (NYSE:ABC) – Research analysts at Jefferies Financial Group issued their FY2019 EPS estimates for AmerisourceBergen in a report issued on Tuesday, January 22nd. Jefferies Financial Group analyst B. Tanquilut forecasts that the company will post earnings of $6.71 per share for the year.

AmerisourceBergen (NYSE:ABC) last posted its quarterly earnings data on Tuesday, November 6th. The company reported $1.45 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.44 by $0.01. AmerisourceBergen had a return on equity of 45.54% and a net margin of 0.99%. The firm had revenue of $43.30 billion during the quarter, compared to analyst estimates of $43.27 billion. During the same period last year, the company posted $1.33 EPS. The business’s quarterly revenue was up 10.7% on a year-over-year basis.

Several other research firms have also weighed in on ABC. Zacks Investment Research raised AmerisourceBergen from a “sell” rating to a “hold” rating in a research report on Friday, November 16th. ValuEngine downgraded AmerisourceBergen from a “hold” rating to a “sell” rating in a research note on Monday, January 7th. Royal Bank of Canada set a $90.00 target price on AmerisourceBergen and gave the company a “hold” rating in a research note on Wednesday, November 7th. TheStreet downgraded AmerisourceBergen from a “b-” rating to a “c+” rating in a research note on Tuesday, January 8th. Finally, UBS Group began coverage on AmerisourceBergen in a research note on Thursday, January 17th. They issued a “buy” rating and a $89.00 target price for the company. One research analyst has rated the stock with a sell rating, seven have given a hold rating and six have issued a buy rating to the company. The company has a consensus rating of “Hold” and a consensus price target of $99.00.

ABC stock opened at $78.70 on Thursday. AmerisourceBergen has a 1-year low of $69.36 and a 1-year high of $106.27. The company has a debt-to-equity ratio of 1.48, a current ratio of 0.93 and a quick ratio of 0.50. The stock has a market capitalization of $16.89 billion, a PE ratio of 12.13, a price-to-earnings-growth ratio of 1.27 and a beta of 1.08.

In other news, insider John G. Chou sold 6,974 shares of the firm’s stock in a transaction dated Thursday, November 15th. The stock was sold at an average price of $88.51, for a total value of $617,268.74. Following the completion of the sale, the insider now directly owns 58,426 shares in the company, valued at approximately $5,171,285.26. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, Chairman Steven H. Collis sold 21,350 shares of the firm’s stock in a transaction dated Thursday, November 1st. The shares were sold at an average price of $90.92, for a total value of $1,941,142.00. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 137,449 shares of company stock valued at $11,818,704. 27.30% of the stock is currently owned by company insiders.

Hedge funds have recently added to or reduced their stakes in the business. Migdal Insurance & Financial Holdings Ltd. boosted its stake in AmerisourceBergen by 140.9% during the 3rd quarter. Migdal Insurance & Financial Holdings Ltd. now owns 1,142 shares of the company’s stock valued at $105,000 after purchasing an additional 668 shares during the last quarter. Financial Gravity Wealth Inc. boosted its stake in AmerisourceBergen by 93.2% during the 3rd quarter. Financial Gravity Wealth Inc. now owns 1,254 shares of the company’s stock valued at $108,000 after purchasing an additional 605 shares during the last quarter. Ipswich Investment Management Co. Inc. acquired a new position in AmerisourceBergen during the 4th quarter valued at about $96,000. Truvestments Capital LLC acquired a new position in AmerisourceBergen during the 3rd quarter valued at about $120,000. Finally, Livingston Group Asset Management CO operating as Southport Capital Management acquired a new position in AmerisourceBergen during the 3rd quarter valued at about $130,000. Institutional investors and hedge funds own 65.94% of the company’s stock.

About AmerisourceBergen

AmerisourceBergen Corporation sources and distributes pharmaceutical products in the United States and internationally. Its Pharmaceutical Distribution segment distributes brand-name and generic pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, outsourced compounded sterile preparations, and related services to various healthcare providers, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and other alternate site pharmacies, and other customers.

Read More: How do candlesticks reflect price movement?

Earnings History and Estimates for AmerisourceBergen (NYSE:ABC)

Receive News & Ratings for AmerisourceBergen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AmerisourceBergen and related companies with MarketBeat.com's FREE daily email newsletter.